ATE350486T1 - Durch mechanischen stress induzierte gene, deren expressionsprodukte und deren verwendung. - Google Patents
Durch mechanischen stress induzierte gene, deren expressionsprodukte und deren verwendung.Info
- Publication number
- ATE350486T1 ATE350486T1 AT99923223T AT99923223T ATE350486T1 AT E350486 T1 ATE350486 T1 AT E350486T1 AT 99923223 T AT99923223 T AT 99923223T AT 99923223 T AT99923223 T AT 99923223T AT E350486 T1 ATE350486 T1 AT E350486T1
- Authority
- AT
- Austria
- Prior art keywords
- genes
- expression products
- mechanical stress
- osteoporosis
- processes
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6809—Methods for determination or identification of nucleic acids involving differential detection
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/136—Screening for pharmacological compounds
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Zoology (AREA)
- Engineering & Computer Science (AREA)
- Analytical Chemistry (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- General Health & Medical Sciences (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Physics & Mathematics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Microbiology (AREA)
- Immunology (AREA)
- Biotechnology (AREA)
- Toxicology (AREA)
- Pathology (AREA)
- Gastroenterology & Hepatology (AREA)
- Medicinal Chemistry (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Saccharide Compounds (AREA)
- Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Apparatus Associated With Microorganisms And Enzymes (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US8567398P | 1998-05-15 | 1998-05-15 |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE350486T1 true ATE350486T1 (de) | 2007-01-15 |
Family
ID=22193209
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT99923223T ATE350486T1 (de) | 1998-05-15 | 1999-05-14 | Durch mechanischen stress induzierte gene, deren expressionsprodukte und deren verwendung. |
Country Status (9)
Country | Link |
---|---|
EP (1) | EP1082463B1 (de) |
JP (1) | JP2002535956A (de) |
AT (1) | ATE350486T1 (de) |
AU (1) | AU4004699A (de) |
CA (1) | CA2332150A1 (de) |
DE (1) | DE69934688T2 (de) |
IL (2) | IL139637A0 (de) |
WO (1) | WO1999060164A1 (de) |
ZA (1) | ZA200006613B (de) |
Families Citing this family (30)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20020151514A1 (en) * | 1998-05-11 | 2002-10-17 | Paz Einat | Genes associated with mechanical stress, expression products therefrom, and uses thereof |
US7034132B2 (en) | 2001-06-04 | 2006-04-25 | Anderson David W | Therapeutic polypeptides, nucleic acids encoding same, and methods of use |
US7259253B2 (en) | 1999-05-14 | 2007-08-21 | Quark Biotech, Inc. | Genes associated with mechanical stress, expression products therefrom, and uses thereof |
AU7863200A (en) | 1999-10-06 | 2001-05-10 | Quark Biotech, Inc. | Method for enrichment of natural antisense messenger rna |
US6986988B2 (en) | 1999-10-06 | 2006-01-17 | Quark Biotech, Inc. | Method for enrichment of natural antisense messenger RNA |
US6468749B1 (en) | 2000-03-30 | 2002-10-22 | Quark Biotech, Inc. | Sequence-dependent gene sorting techniques |
WO2002046753A1 (fr) * | 2000-12-06 | 2002-06-13 | Takara Bio Inc. | Reseau d'adn fonctionnel |
EP1370576A4 (de) * | 2001-03-23 | 2005-06-01 | Dana Farber Cancer Inst Inc | Verfahren und zusammensetzungen zur modulation der tumorsuppression |
US20030191073A1 (en) | 2001-11-07 | 2003-10-09 | Challita-Eid Pia M. | Nucleic acid and corresponding protein entitled 161P2F10B useful in treatment and detection of cancer |
BE1014949A3 (fr) * | 2001-08-14 | 2004-07-06 | Probiox | Procede de detection de stress oxydant et trousse pour sa mise en oeuvre. |
JP4200100B2 (ja) | 2001-11-07 | 2008-12-24 | アジェンシス,インコーポレイテッド | 癌の処置および検出において有用な161p2f10bと称される、核酸および対応タンパク質 |
BRPI0411020A (pt) * | 2003-06-06 | 2006-07-18 | Wyeth Corp | perfil de expressão de gene, métodos de identificar agentes modulares do caminho de wnt, de preparar um perfil de expressão de gene, de triar um agente que realce a remodelagem associada com a carga óssea e reagentes que se ligam às proteìnas que modulam a remodelagem óssea e/ou mineralização óssea, de tratar uma doença ou distúrbio de mineralização óssea, de modular a mineralização óssea em uma célula e a mineralização óssea e/ou remodelagem óssea em um paciente e de determinar se um composto ou uma composição realçam o efeito de carga óssea na atividade/função e/ou mineralização da célula óssea, agente candidato para tratar uma condição de massa óssea baixa e composição |
US8569234B2 (en) | 2004-10-08 | 2013-10-29 | Clinuvel Pharmaceuticals Limited | Compositions and methods for including melanogenesis in a subject |
RU2413735C2 (ru) | 2005-03-31 | 2011-03-10 | Эдженсис, Инк. | Антитела и родственные молекулы, связывающиеся с белками 161p2f10b |
US8350009B2 (en) | 2005-03-31 | 2013-01-08 | Agensys, Inc. | Antibodies and related molecules that bind to 161P2F10B proteins |
CN101365484A (zh) | 2005-08-15 | 2009-02-11 | 瓦克辛公司 | 通过给药非复制型载体化疫苗而进行的对禽类的免疫 |
FR2893328B1 (fr) * | 2005-11-17 | 2014-01-31 | Lvmh Rech | Procede pour depister des marqueurs impliques dans la resistance de keratinocytes a des deformations mecaniques. |
SI2056855T1 (sl) | 2006-08-31 | 2015-01-30 | Clinuvel Pharmaceuticals Limited | Alfa-msh derivati za zdravljenje fotodermazoze |
ES2656131T3 (es) | 2008-03-27 | 2018-02-23 | Clinuvel Pharmaceuticals Limited | Terapia para el vitíligo |
CN102844045A (zh) | 2010-02-08 | 2012-12-26 | 艾更斯司股份有限公司 | 结合于161p2f10b蛋白的抗体药物偶联物(adc) |
EP2487185A1 (de) | 2011-02-11 | 2012-08-15 | Clinuvel Pharmaceuticals Limited | Hexapeptid mit verbesserter Aktivität bei der Reparatur von zellulärer DNA von Dermiszellen |
KR20200044990A (ko) | 2011-03-21 | 2020-04-29 | 알티뮨 인크. | 급속 및 지속적 면역학적제제-치료제 |
CN103841963B (zh) | 2011-08-12 | 2018-04-24 | 梅里亚股份有限公司 | 用于生物产品特别是疫苗的真空辅助保存 |
WO2014012090A1 (en) | 2012-07-13 | 2014-01-16 | The Broad Institute, Inc. | Molecular sleds comprising a positively-charged amino acid sequence and a molecular cargo and uses thereof |
EP3494997B1 (de) | 2012-07-25 | 2019-09-18 | The Broad Institute, Inc. | Induzierbare dns-bindende proteine und genomperturbationstools sowie anwendungen davon |
WO2014121104A1 (en) * | 2013-01-31 | 2014-08-07 | The Regents Of The University Of California | Pooled genetic perturbation effects |
US11332719B2 (en) | 2013-03-15 | 2022-05-17 | The Broad Institute, Inc. | Recombinant virus and preparations thereof |
WO2015057671A1 (en) | 2013-10-14 | 2015-04-23 | The Broad Institute, Inc. | Artificial transcription factors comprising a sliding domain and uses thereof |
JP6545084B2 (ja) * | 2015-11-11 | 2019-07-17 | 株式会社Adeka | 潤滑油組成物及びその製造方法 |
US20240254510A1 (en) * | 2021-03-19 | 2024-08-01 | Washington University | Methods for generating mechanically-responsive cells and uses thereof |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
MX9204303A (es) * | 1991-07-23 | 1993-11-01 | Rhone Poulenc Rorer Int | Factor regulador del crecimiento de osteoclasto. |
US5445941A (en) * | 1993-06-21 | 1995-08-29 | Eli Lilly And Company | Method for screening anti-osteoporosis agents |
US5763416A (en) * | 1994-02-18 | 1998-06-09 | The Regent Of The University Of Michigan | Gene transfer into bone cells and tissues |
US5834248A (en) * | 1995-02-10 | 1998-11-10 | Millennium Pharmaceuticals Inc. | Compositions and methods using rchd534, a gene uregulated by shear stress |
US5861249A (en) * | 1996-04-23 | 1999-01-19 | Cold Spring Harbor Laboratory | Assays and reagents for identifying modulators of cdc25-mediated mitotic activation |
-
1999
- 1999-05-14 DE DE69934688T patent/DE69934688T2/de not_active Expired - Fee Related
- 1999-05-14 AU AU40046/99A patent/AU4004699A/en not_active Abandoned
- 1999-05-14 JP JP2000549770A patent/JP2002535956A/ja active Pending
- 1999-05-14 EP EP99923223A patent/EP1082463B1/de not_active Expired - Lifetime
- 1999-05-14 CA CA002332150A patent/CA2332150A1/en not_active Abandoned
- 1999-05-14 IL IL13963799A patent/IL139637A0/xx unknown
- 1999-05-14 AT AT99923223T patent/ATE350486T1/de not_active IP Right Cessation
- 1999-05-14 WO PCT/US1999/011066 patent/WO1999060164A1/en active IP Right Grant
-
2000
- 2000-11-13 IL IL139637A patent/IL139637A/en active IP Right Grant
- 2000-11-14 ZA ZA200006613A patent/ZA200006613B/en unknown
Also Published As
Publication number | Publication date |
---|---|
WO1999060164A1 (en) | 1999-11-25 |
AU4004699A (en) | 1999-12-06 |
IL139637A (en) | 2009-09-22 |
ZA200006613B (en) | 2002-02-14 |
EP1082463A1 (de) | 2001-03-14 |
EP1082463B1 (de) | 2007-01-03 |
JP2002535956A (ja) | 2002-10-29 |
DE69934688D1 (de) | 2007-02-15 |
IL139637A0 (en) | 2002-02-10 |
DE69934688T2 (de) | 2007-10-18 |
EP1082463A4 (de) | 2003-05-21 |
CA2332150A1 (en) | 1999-11-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69934688D1 (de) | Durch mechanischen stress induzierte gene, deren expressionsprodukte und deren verwendung. | |
Stewart et al. | ApoE genotype, past adult lead exposure, and neurobehavioral function. | |
DK1005540T3 (da) | IKK-beta-proteiner, nukleinsyrer og fremgangsmåder | |
CY1108716T1 (el) | Μεθοδος διαγνωσεως της νοσου του alzheimer με βαση μια μορφη μεταγραφης γονιδιου. | |
DE60233485D1 (de) | Verfahren zur diagnose, behandlung und prävention von knochenverlust | |
BR122016004546B8 (pt) | vírus adenoassociado recombinante, método de geração do referido vírus e composição compreendendo o referido vírus | |
ES2530843T3 (es) | Métodos basados en microARN para el diagnóstico de cáncer de páncreas | |
ATE295374T1 (de) | Hu-b1.219, ein neuartiger hämatopoietinrezeptor | |
ATE310955T1 (de) | Zusammensetzungen und verfahren zum nachweis und zur behandlung von mit chemokinrezeptoren verbundenen krankheiten | |
DE602004016499D1 (de) | Zusammensetzungen und verfahren zur behandlung von entzündlicher darmerkrankung | |
HUP0301581A2 (hu) | Sejteken prezentált peptidek | |
CY1108568T1 (el) | Αναστολεας για διαγνωση και θεραπεια ασθενων με αιμορροφιλια α | |
NO20072076L (no) | VWFA og/eller ANT_IG holdige proteiner | |
DE69826493D1 (de) | Ikk-alpha proteine, nukleinsäuren und verfahren | |
WO2009108791A8 (en) | Diagnostic skin mapping by mrs, mri and other methods | |
WO1999051186A3 (en) | Methods and compositions for the diagnosis and treatment of neuropsychiatric disorders | |
ATE480641T1 (de) | Zusammensetzungen, reagenzien, kits und verfahren für die diagnose und behandlung von fettleibigkeit und/oder diabetes | |
DE602005013430D1 (de) | Verwendung von asc als marker für kolorektalkarzinome | |
Millett et al. | Chlorhexidine-modified glass ionomer forbandcementation? An in vitro study | |
SI1565573T1 (sl) | Sonde nukleinske kisline in primerji širokega območja iz regij v topoizomeraznih genih ter postopki, pri katerih jih uporabljamo | |
ATE527376T1 (de) | Pna-sonden, sondensätze, verfahren und kits im zusammenhang mit dem nachweis von candida | |
ATE534037T1 (de) | Verwendung des proteins asc als marker für brustkrebs | |
WO2003063689A3 (en) | Islr gene and its association with osteoarthritis and other bone and cartilage disorders, expression products derived therefrom, and uses thereof | |
DE59904870D1 (de) | Antisense-sequenzen für die hemmung der expression des adhäsionsmoleküls icam-1 | |
WO2003103597A3 (en) | DIAGNOSIS AND TREATMENT OF DIABETES AND INSULIN RESISTANCE |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |